‘With a bright future in the compliance space’, associate director Catalina Jimenez A heads up OlarteMoure’s , growing practice in the sector, advising multinationals, (primarily pharmaceutical companies), on compliance and the mitigation of risks associated with anti-corruption, foreign bribery, FCPA and Anti-bribery Act issues.

Legal 500 Editorial commentary